APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cytomegalovirus (CMV) Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cytomegalovirus (CMV) Vaccine Industry Growth and Trends Forecast to 2032

29 December 202579 pages

Choose your research edition.

Industry ResearchCytomegalovirus (CMV) Vaccine Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Cytomegalovirus (CMV) Vaccine Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Cytomegalovirus (CMV) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cytomegalovirus (CMV) Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Cytomegalovirus (CMV) Vaccine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Cytomegalovirus (CMV) Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cytomegalovirus (CMV) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cytomegalovirus (CMV) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cytomegalovirus (CMV) Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cytomegalovirus (CMV) Vaccine include AlphaVax, Moderna, Merck and Novartis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cytomegalovirus (CMV) Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cytomegalovirus (CMV) Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cytomegalovirus (CMV) Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cytomegalovirus (CMV) Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cytomegalovirus (CMV) Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cytomegalovirus (CMV) Vaccine Market by Company

AlphaVax

Moderna

Merck

Novartis

Cytomegalovirus (CMV) Vaccine Segment by Type

Attenuated Vaccines

Subunit Vaccines

Cytomegalovirus (CMV) Vaccine Segment by Application

Laboratories

Hospitals

Diagnostic Centers and Clinics

Others

Cytomegalovirus (CMV) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cytomegalovirus (CMV) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cytomegalovirus (CMV) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cytomegalovirus (CMV) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cytomegalovirus (CMV) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cytomegalovirus (CMV) Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Attenuated Vaccines Table 2. Major Company of Subunit Vaccines Table 3. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 5. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Cytomegalovirus (CMV) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2027-2032) & (K Units) Table 10. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cytomegalovirus (CMV) Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Cytomegalovirus (CMV) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 15. North America Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 17. Europe Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Cytomegalovirus (CMV) Vaccine Industry Trends Table 25. Cytomegalovirus (CMV) Vaccine Industry Drivers Table 26. Cytomegalovirus (CMV) Vaccine Industry Opportunities and Challenges Table 27. Cytomegalovirus (CMV) Vaccine Industry Restraints Table 28. Global Cytomegalovirus (CMV) Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Cytomegalovirus (CMV) Vaccine Sales by Company (2021-2026) & (K Units) Table 31. Global Cytomegalovirus (CMV) Vaccine Sales Share by Company (2021-2026) Table 32. Global Cytomegalovirus (CMV) Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cytomegalovirus (CMV) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cytomegalovirus (CMV) Vaccine Major Company Production Sites and Headquarters Table 35. Global Cytomegalovirus (CMV) Vaccine Company, Product Type & Application Table 36. Global Cytomegalovirus (CMV) Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cytomegalovirus (CMV) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cytomegalovirus (CMV) Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2021-2026) & (K Units) Table 41. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Cytomegalovirus (CMV) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Cytomegalovirus (CMV) Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Cytomegalovirus (CMV) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2027-2032) & (K Units) Table 57. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cytomegalovirus (CMV) Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Cytomegalovirus (CMV) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 62. North America Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 64. Europe Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. AlphaVax Company Information Table 72. AlphaVax Business Overview Table 73. AlphaVax Cytomegalovirus (CMV) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. AlphaVax Cytomegalovirus (CMV) Vaccine Product Portfolio Table 75. AlphaVax Recent Development Table 76. Moderna Company Information Table 77. Moderna Business Overview Table 78. Moderna Cytomegalovirus (CMV) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Moderna Cytomegalovirus (CMV) Vaccine Product Portfolio Table 80. Moderna Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Cytomegalovirus (CMV) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Merck Cytomegalovirus (CMV) Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Cytomegalovirus (CMV) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Novartis Cytomegalovirus (CMV) Vaccine Product Portfolio Table 90. Novartis Recent Development Table 91. North America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 92. North America Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026) & (K Units) Table 93. North America Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2021-2026) Table 94. North America Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 95. North America Cytomegalovirus (CMV) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 96. North America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. North America Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 98. North America Cytomegalovirus (CMV) Vaccine Market Share by Country (2021-2026) Table 99. North America Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. North America Cytomegalovirus (CMV) Vaccine Market Share Forecast by Country (2027-2032) Table 101. Europe Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026) & (K Units) Table 103. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2021-2026) Table 104. Europe Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 105. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 106. Europe Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Europe Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 108. Europe Cytomegalovirus (CMV) Vaccine Market Share by Country (2021-2026) Table 109. Europe Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Europe Cytomegalovirus (CMV) Vaccine Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026) & (K Units) Table 113. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2021-2026) Table 114. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 115. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 118. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Share by Country (2021-2026) Table 119. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Share Forecast by Country (2027-2032) Table 121. Latin America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026) & (K Units) Table 123. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2021-2026) Table 124. Latin America Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 125. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 126. Latin America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Latin America Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 128. Latin America Cytomegalovirus (CMV) Vaccine Market Share by Country (2021-2026) Table 129. Latin America Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Latin America Cytomegalovirus (CMV) Vaccine Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026) & (K Units) Table 133. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2021-2026) Table 134. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 135. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 138. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Share by Country (2021-2026) Table 139. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Share Forecast by Country (2027-2032) Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Cytomegalovirus (CMV) Vaccine Distributors List Table 144. Cytomegalovirus (CMV) Vaccine Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Cytomegalovirus (CMV) Vaccine Image Figure 2. Global Cytomegalovirus (CMV) Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cytomegalovirus (CMV) Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cytomegalovirus (CMV) Vaccine Sales (2021-2032) & (K Units) Figure 5. Attenuated Vaccines Image Figure 6. Global Attenuated Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 7. Subunit Vaccines Image Figure 8. Global Subunit Vaccines Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cytomegalovirus (CMV) Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cytomegalovirus (CMV) Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cytomegalovirus (CMV) Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Laboratories Image Figure 24. Global Laboratories Sales YoY Growth (2021-2032) & (K Units) Figure 25. Hospitals Image Figure 26. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 27. Diagnostic Centers and Clinics Image Figure 28. Global Diagnostic Centers and Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cytomegalovirus (CMV) Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cytomegalovirus (CMV) Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Cytomegalovirus (CMV) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cytomegalovirus (CMV) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cytomegalovirus (CMV) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cytomegalovirus (CMV) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cytomegalovirus (CMV) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cytomegalovirus (CMV) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cytomegalovirus (CMV) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cytomegalovirus (CMV) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cytomegalovirus (CMV) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cytomegalovirus (CMV) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cytomegalovirus (CMV) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cytomegalovirus (CMV) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cytomegalovirus (CMV) Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cytomegalovirus (CMV) Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Attenuated Vaccines
  • Subunit Vaccines
Applications
  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others
Companies covered
  • AlphaVax
  • Moderna
  • Merck
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cytomegalovirus (CMV) Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cytomegalovirus (CMV) Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cytomegalovirus (CMV) Vaccine Market by Type
  6. 1.3.1 Attenuated Vaccines
  7. 1.3.2 Subunit Vaccines
  8. 1.4 Global Cytomegalovirus (CMV) Vaccine Market Size by Type
  9. 1.4.1 Global Cytomegalovirus (CMV) Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cytomegalovirus (CMV) Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cytomegalovirus (CMV) Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cytomegalovirus (CMV) Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cytomegalovirus (CMV) Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cytomegalovirus (CMV) Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cytomegalovirus (CMV) Vaccine Industry Trends
  2. 2.2 Cytomegalovirus (CMV) Vaccine Industry Drivers
  3. 2.3 Cytomegalovirus (CMV) Vaccine Industry Opportunities and Challenges
  4. 2.4 Cytomegalovirus (CMV) Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cytomegalovirus (CMV) Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Cytomegalovirus (CMV) Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Cytomegalovirus (CMV) Vaccine Price (2021-2026)
  4. 3.4 Global Cytomegalovirus (CMV) Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cytomegalovirus (CMV) Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Cytomegalovirus (CMV) Vaccine Company, Product Type & Application
  7. 3.7 Global Cytomegalovirus (CMV) Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cytomegalovirus (CMV) Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cytomegalovirus (CMV) Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cytomegalovirus (CMV) Vaccine Tier 1, Tier 2, and Tier 3
4 Cytomegalovirus (CMV) Vaccine Regional Status and Outlook
  1. 4.1 Global Cytomegalovirus (CMV) Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cytomegalovirus (CMV) Vaccine Historic Market Size by Region
  3. 4.2.1 Global Cytomegalovirus (CMV) Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cytomegalovirus (CMV) Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cytomegalovirus (CMV) Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cytomegalovirus (CMV) Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Cytomegalovirus (CMV) Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cytomegalovirus (CMV) Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cytomegalovirus (CMV) Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cytomegalovirus (CMV) Vaccine by Application
  1. 5.1 Cytomegalovirus (CMV) Vaccine Market by Application
  2. 5.1.1 Laboratories
  3. 5.1.2 Hospitals
  4. 5.1.3 Diagnostic Centers and Clinics
  5. 5.1.4 Others
  6. 5.2 Global Cytomegalovirus (CMV) Vaccine Market Size by Application
  7. 5.2.1 Global Cytomegalovirus (CMV) Vaccine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Cytomegalovirus (CMV) Vaccine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Cytomegalovirus (CMV) Vaccine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Cytomegalovirus (CMV) Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Cytomegalovirus (CMV) Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Cytomegalovirus (CMV) Vaccine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 AlphaVax
  2. 6.1.1 AlphaVax Company Information
  3. 6.1.2 AlphaVax Business Overview
  4. 6.1.3 AlphaVax Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 AlphaVax Cytomegalovirus (CMV) Vaccine Product Portfolio
  6. 6.1.5 AlphaVax Recent Developments
  7. 6.2 Moderna
  8. 6.2.1 Moderna Company Information
  9. 6.2.2 Moderna Business Overview
  10. 6.2.3 Moderna Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Moderna Cytomegalovirus (CMV) Vaccine Product Portfolio
  12. 6.2.5 Moderna Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Cytomegalovirus (CMV) Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Cytomegalovirus (CMV) Vaccine Product Portfolio
  24. 6.4.5 Novartis Recent Developments
7 North America by Country
  1. 7.1 North America Cytomegalovirus (CMV) Vaccine Sales by Country
  2. 7.1.1 North America Cytomegalovirus (CMV) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cytomegalovirus (CMV) Vaccine Market Size by Country
  6. 7.2.1 North America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cytomegalovirus (CMV) Vaccine Sales by Country
  2. 8.1.1 Europe Cytomegalovirus (CMV) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cytomegalovirus (CMV) Vaccine Market Size by Country
  6. 8.2.1 Europe Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cytomegalovirus (CMV) Vaccine Sales by Country
  2. 10.1.1 South America Cytomegalovirus (CMV) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cytomegalovirus (CMV) Vaccine Market Size by Country
  6. 10.2.1 South America Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cytomegalovirus (CMV) Vaccine Value Chain Analysis
  2. 12.1.1 Cytomegalovirus (CMV) Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cytomegalovirus (CMV) Vaccine Production Mode & Process
  7. 12.2 Cytomegalovirus (CMV) Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cytomegalovirus (CMV) Vaccine Distributors
  10. 12.2.3 Cytomegalovirus (CMV) Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst